Interim Analysis Of Functional Outcomes After Implantation Of Monofocal+ Intraocular Lenses Inducing Positive Spherical Aberration Without Monovision
Published 2024 - 42nd Congress of the ESCRS
Reference: PO333 | Type: Free paper | DOI: 10.82333/cdtx-nb25
Authors: Lizaveta Chychko* 1 , Oliver Hassel 1 , Emanuel Reitemeyer 1 , Ramin Khoramnia 1 , Gerd Uwe Auffarth 1
1Ophthalmology,University Eye Clinic Heidelberg,Heidelberg,Germany
Purpose
To evaluate the functional outcomes including visual performance and patient reported outcomes after implantation of the enhanced monofocal lenses RayOne EMV and RayOne EMV toric RAO210T (Rayner, UK).
Setting
International Vision Correction Research Centre (IVCRC), Department of Ophthalmology, University Hospital Heidelberg, Germany.
Methods
This ongoing prospective study examines the visual outcomes of phacoemulsification combined with RayOne EMV and RayOne EMV toric RAO210T intraocular lens (IOL) implantation in 9 patients (13 eyes) and 8 patients (16 eyes) respectively, with an average age of 72 ± 9 years. Postoperative assessments at 1, 3, 6, and 12 months include uncorrected and corrected distance visual acuity (UDVA, CDVA), uncorrected and distance corrected intermediate visual acuity (UIVA, DCIVA) at 66 cm, and uncorrected and distance corrected near visual acuity (UNVA, DCNVA) at 40 cm. Binocular best-corrected defocus curve analysis ranging from +2 to -4 diopters was performed at 3 and 6 months post-surgery.
Results
At 1 month postoperative, mean monocular visual acuity in logMAR was UDVA/CDVA (0.07/-0.01), UIVA/CIVA (0.19/0.20), and UNVA/CNVA (0.41/0.44). At 3 months follow-up, mean monocular visual acuity in logMAR was UDVA/CDVA (0.02/-0.05), UIVA/CIVA (0.23/0.22), and UNVA/CNVA (0.48/0.46). At 6 months, mean monocular visual acuity in logMAR was UDVA/CDVA (0.03/-0.04), UIVA/CIVA (0.19/0.21), and UNVA/CNVA (0.44/0.45). By 12 months, mean monocular visual acuity in logMAR was UDVA/CDVA (0.00/-0.10), UIVA/CIVA (0.27/0.29), and UNVA/CNVA (0.30/0.31).
Conclusions
Preliminary findings suggest satisfactory visual acuity outcomes and reduced photopic phenomena. IOL power calculation and implantation procedures for RayOne EMV and RayOne EMV toric lenses appear straightforward. Ongoing evaluation will further elucidate visual outcomes at 6 and 12 months postoperatively.